Literature DB >> 23030059

Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis.

L Ouyang1, Z Shi, S Zhao, F-T Wang, T-T Zhou, B Liu, J-K Bao.   

Abstract

Programmed cell death (PCD), referring to apoptosis, autophagy and programmed necrosis, is proposed to be death of a cell in any pathological format, when mediated by an intracellular program. These three forms of PCD may jointly decide the fate of cells of malignant neoplasms; apoptosis and programmed necrosis invariably contribute to cell death, whereas autophagy can play either pro-survival or pro-death roles. Recent bulk of accumulating evidence has contributed to a wealth of knowledge facilitating better understanding of cancer initiation and progression with the three distinctive types of cell death. To be able to decipher PCD signalling pathways may aid development of new targeted anti-cancer therapeutic strategies. Thus in this review, we present a brief outline of apoptosis, autophagy and programmed necrosis pathways and apoptosis-related microRNA regulation, in cancer. Taken together, understanding PCD and the complex interplay between apoptosis, autophagy and programmed necrosis may ultimately allow scientists and clinicians to harness the three types of PCD for discovery of further novel drug targets, in the future cancer treatment.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23030059      PMCID: PMC6496669          DOI: 10.1111/j.1365-2184.2012.00845.x

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  116 in total

Review 1.  Targeting the Raf kinase cascade in cancer therapy--novel molecular targets and therapeutic strategies.

Authors:  John T Lee; James A McCubrey
Journal:  Expert Opin Ther Targets       Date:  2002-12       Impact factor: 6.902

2.  Molecular cloning of the akt oncogene and its human homologues AKT1 and AKT2: amplification of AKT1 in a primary human gastric adenocarcinoma.

Authors:  S P Staal
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

3.  Absence of oncogenic mutations of RAS family genes in soft tissue sarcomas of 100 Japanese patients.

Authors:  Yonghui Jin; Yasuko Shima; Moritoshi Furu; Tomoki Aoyama; Takeharu Nakamata; Tomitaka Nakayama; Takashi Nakamura; Junya Toguchida
Journal:  Anticancer Res       Date:  2010-01       Impact factor: 2.480

4.  Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3.

Authors:  H Zou; W J Henzel; X Liu; A Lutschg; X Wang
Journal:  Cell       Date:  1997-08-08       Impact factor: 41.582

5.  The Beclin 1 interactome.

Authors:  Congcong He; Beth Levine
Journal:  Curr Opin Cell Biol       Date:  2010-01-22       Impact factor: 8.382

Review 6.  Regulation mechanisms and signaling pathways of autophagy.

Authors:  Congcong He; Daniel J Klionsky
Journal:  Annu Rev Genet       Date:  2009       Impact factor: 16.830

7.  The atypical PKC-interacting protein p62 is an important mediator of RANK-activated osteoclastogenesis.

Authors:  Angeles Durán; Manuel Serrano; Michael Leitges; Juana M Flores; Sylvain Picard; Jacques P Brown; Jorge Moscat; Maria T Diaz-Meco
Journal:  Dev Cell       Date:  2004-02       Impact factor: 12.270

8.  Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex.

Authors:  James Brugarolas; Kui Lei; Rebecca L Hurley; Brendan D Manning; Jan H Reiling; Ernst Hafen; Lee A Witters; Leif W Ellisen; William G Kaelin
Journal:  Genes Dev       Date:  2004-11-15       Impact factor: 11.361

Review 9.  The Ras protein superfamily: evolutionary tree and role of conserved amino acids.

Authors:  Ana Maria Rojas; Gloria Fuentes; Antonio Rausell; Alfonso Valencia
Journal:  J Cell Biol       Date:  2012-01-23       Impact factor: 10.539

10.  Tor-mediated induction of autophagy via an Apg1 protein kinase complex.

Authors:  Y Kamada; T Funakoshi; T Shintani; K Nagano; M Ohsumi; Y Ohsumi
Journal:  J Cell Biol       Date:  2000-09-18       Impact factor: 10.539

View more
  423 in total

1.  Coffee provides a natural multitarget pharmacopeia against the hallmarks of cancer.

Authors:  François Gaascht; Mario Dicato; Marc Diederich
Journal:  Genes Nutr       Date:  2015-11-17       Impact factor: 5.523

2.  T-cell development of resistance to apoptosis is driven by a metabolic shift in carbon source and altered activation of death pathways.

Authors:  C D Bortner; A B Scoltock; D W Cain; J A Cidlowski
Journal:  Cell Death Differ       Date:  2015-12-11       Impact factor: 15.828

Review 3.  Cell death in genome evolution.

Authors:  Xinchen Teng; J Marie Hardwick
Journal:  Semin Cell Dev Biol       Date:  2015-02-25       Impact factor: 7.727

Review 4.  Bacterial programmed cell death: making sense of a paradox.

Authors:  Kenneth W Bayles
Journal:  Nat Rev Microbiol       Date:  2014-01       Impact factor: 60.633

5.  Bisindolylmaleimide alkaloid BMA-155Cl induces autophagy and apoptosis in human hepatocarcinoma HepG-2 cells through the NF-κB p65 pathway.

Authors:  Xiao Sun; Lin Li; Hong-Guang Ma; Pu Sun; Qi-Lin Wang; Ting-Ting Zhang; Yue-Mao Shen; Wei-Ming Zhu; Xia Li
Journal:  Acta Pharmacol Sin       Date:  2017-03-06       Impact factor: 6.150

6.  Resilience of death: intrinsic disorder in proteins involved in the programmed cell death.

Authors:  Z Peng; B Xue; L Kurgan; V N Uversky
Journal:  Cell Death Differ       Date:  2013-06-14       Impact factor: 15.828

Review 7.  Could plant lectins become promising anti-tumour drugs for causing autophagic cell death?

Authors:  Z Liu; Y Luo; T-T Zhou; W-Z Zhang
Journal:  Cell Prolif       Date:  2013-08-24       Impact factor: 6.831

8.  Andrographolide inhibits proliferation and induces cell cycle arrest and apoptosis in human melanoma cells.

Authors:  Guo Liu; Haihan Chu
Journal:  Oncol Lett       Date:  2018-02-02       Impact factor: 2.967

Review 9.  Apoptotic pathways as a therapeutic target for colorectal cancer treatment.

Authors:  Aman M Abraha; Ezra B Ketema
Journal:  World J Gastrointest Oncol       Date:  2016-08-15

Review 10.  A challenge to the striking genotypic heterogeneity of retinitis pigmentosa: a better understanding of the pathophysiology using the newest genetic strategies.

Authors:  F S Sorrentino; C E Gallenga; C Bonifazzi; P Perri
Journal:  Eye (Lond)       Date:  2016-08-26       Impact factor: 3.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.